Quarterly report pursuant to Section 13 or 15(d)

LICENSE/SUPPLIER AGREEMENT (Details Narrative)

v3.24.1.1.u2
LICENSE/SUPPLIER AGREEMENT (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
May 16, 2022
Oct. 31, 2020
Aug. 31, 2020
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Revenue recognized        
License Agreement Terms [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Milestone payments $ 30,000,000.0          
Sublicense And Inventory Purchase Agreements [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Fixed consideration     $ 7,000,000.0      
Sublicense And Inventory Purchase Agreements [Member] | Event Based Milestone Payments [Member] | Maximum [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Variable consideration     26,000,000.0      
Sublicense And Inventory Purchase Agreements [Member] | Sales Based Milestone Payments [Member] | Maximum [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Variable consideration     $ 30,000,000.0      
Sublicense And Inventory Purchase Agreements [Member] | License [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Revenue recognized       0 0  
Contract assets       0   $ 0
Sublicense Agreement Relating to Rett Syndrome [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Fixed consideration   $ 3,000,000.0        
Sublicense Agreement Relating to Rett Syndrome [Member] | Event Based Milestone Payments [Member] | Maximum [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Variable consideration   26,500,000        
Sublicense Agreement Relating to Rett Syndrome [Member] | Sales Based Milestone Payments [Member] | Maximum [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Variable consideration   $ 30,000,000.0        
Sublicense Agreement Relating to Rett Syndrome [Member] | License [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Revenue recognized       $ 0 $ 0